Indeed, P2X7 receptor upregulation in brain tumor cells is a good prognostic predictor for radiation therapy response, and P2X7 receptor agonists have been shown to potentialize the cytotoxic effect of anticancer agents (4–6). This evidence concerns the gene P2RX7 and brain neoplasm.